Senior insider sale
President and COO at BICARA THERAPEUTICS INC. — senior position signals high conviction
$1.75M
65K shares
What this filing means
COHLHEPP RYAN plans to sell 65K shares of BICARA THERAPEUTICS INC. valued at approximately $1.75M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/8/2026ACC: 0001969223-26-001008
DirectorOfficer· President and COO
Since Mar 2026
65K
Shares to sell
$1.75M
Approx. market value
17.50K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Option
Cash
9/8/2026
17.50KTotal acquired17.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2026 | Exercise of Stock Option Cash | 17.50K | — |
| Total | 17.50K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
18.75K
Market value
$524.5K
8/10/2026
—Completed
Units to sell
536.00
Market value
$15.5K
7/9/2026
—Completed
Units to sell
28.21K
Market value
$817.6K
7/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
17.50K
Market value
$396.2K
9/8/2026
Total
Units
65K
Value
$1.75M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/10/2026 | 18.75K | $524.5K | — | Completed |
7/9/2026 | 536.00 | $15.5K | — | Completed |
7/8/2026 | 28.21K | $817.6K | — | Completed |
| Planned — Approximate Date | ||||
9/8/2026 | 17.50K | $396.2K | NASDAQ | Planned |
| Total | 65K | $1.75M | ||